ArticleBMJ public health2026
Sociodemographic correlates of human papillomavirus and hepatitis B vaccination status in Canada: a cross-sectional study.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Implementing single-dose HPV vaccination in Canada.Human vaccines & immunotherapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Human papillomavirus (HPV) and hepatitis B (HBV) vaccines are critical to cancer prevention strategies; however, achieving high vaccination coverage remains a challenge. We aimed to investigate the proportion of Canadian 14-year-old children who received these vaccines by child's gender and examine sociodemographic factors associated with vaccination. Methods: We used a cross-sectional design to analyse data from the 2021 Childhood National Immunization Coverage Survey. Data were collected using self-completed electronic questionnaires or telephone interviews. Parents/guardians of 14-year-old children separately reported their child's 1-dose HPV and 1-dose HBV vaccination status (categorised as vaccinated, unvaccinated or unknown vaccination status), and their sociodemographic characteristics. Univariable multinomial logistic regression models were used to calculate vaccination status by sociodemographic variables. Results: After weights were applied, the final weighted sample size was 413 255 and 413 710 respondents for the HPV and HBV samples, respectively. Uptake of 1 dose of the HPV and HBV vaccines was 74.9% and 78.7%, respectively, with higher uptake in girls compared with boys for HPV (80.0% vs 69.9%) and HBV (80.9% vs 76.4%). Having more children in the home was associated with higher odds of being HPV unvaccinated. Less parent education, being born outside Canada, being a boy and having an Indigenous identity were associated with higher odds of an unknown HPV vaccination status. Older parent age and less parent education were associated with higher odds of being HBV unvaccinated. Less parent education and parents who were not married/common law were associated with higher odds of an unknown HBV vaccination status, while older parent age and residing in Quebec were associated with lower odds. Conclusions: HPV and HBV vaccination coverage in Canada did not reach national and global targets of 90% in 2021. This study highlights sociodemographic disparities in vaccine uptake, which were unique to each vaccine and vaccination status. These findings provide evidence of inequities that should be systematically monitored.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.